Related Experiment Video

Updated: May 24, 2025

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

58.9K

Host cell entry and neutralisation sensitivity of the emerging SARS-CoV-2 variant LP.8.1

Lu Zhang1, Amy Kempf2, Inga Nehlmeier1

  • 1Infection Biology Unit, German Primate Center, 37077 Göttingen, Germany.

The Lancet. Infectious Diseases
|March 1, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.3K
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.3K

Related Experiment Videos

Last Updated: May 24, 2025

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

58.9K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.3K
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.3K

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

725
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
725

Articles linked to this work by shared authors, journal, and citation graph.

Longitudinal observation of persistent Long COVID symptoms and health-related quality of life in an adult German cohort.

BMC infectious diseases·2026

The economic impact of pediatric RSV-related lower respiratory tract infection in Germany: evidence from the PAPI study.

Journal of medical economics·2026

Whole-blood CD3/CD28-stimulated cytokine responses in children with preschool wheeze, asthma, and healthy controls.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026

The conserved QTQTX motif in the SARS-CoV-2 spike protein is dispensable for cleavage and lung cell entry of the emerging variant BA.3.2.

Journal of virology·2026

JN.1-adapted vaccination is associated with readjustment of ancestral memory B cells toward neutralization within the JN.1 antigenic space.

Nature communications·2026

Systemic inflammatory networks in HIV-associated chronic obstructive pulmonary disease.

The Journal of infection·2026

Severe health-care-associated infections and antimicrobial resistance in an Asian Surveillance Network (ACORN-HAI): a multicentre, prospective cohort study.

The Lancet. Infectious diseases·2026

Azithromycin with or without cefixime for suspected or culture-confirmed uncomplicated typhoid fever in Nepal, Bangladesh, and Pakistan (ACT-South Asia): a double-blind, parallel-group, randomised, placebo-controlled, phase 4 trial.

The Lancet. Infectious diseases·2026

Epidemiological impact of a dual-action insecticidal coating applied to Aedes aegypti breeding sites on dengue transmission in Colombia: a cluster-randomised trial.

The Lancet. Infectious diseases·2026

Safety and immunogenicity of the synthetic carbohydrate conjugate vaccine, SF2a-TT15, against Shigella flexneri 2a in infants in Kenya: a phase 2a, age-descending, dose-escalating, double-blind, randomised, placebo-controlled study.

The Lancet. Infectious diseases·2026

Congenital tuberculosis presenting as acute cervical lymphadenitis in a 28-week preterm infant.

The Lancet. Infectious diseases·2026

Comparison of VPM1002 with BCG in the prevention of tuberculosis in newborn infants: a multicentre, double-blind, randomised, phase 3, non-inferiority trial.

The Lancet. Infectious diseases·2026

Impact of immunotherapy in the treatment of early-stage non-small lung cancer, melanoma, and colorectal cancer.

Immunotherapy·2026

Biochemical, radiological and histological effects of ixekizumab on skin tissue in a bleomycin-induced systemic sclerosis mouse model.

Clinical and experimental rheumatology·2026

A Multicentre Experience of Inner-Branched Endovascular Aneurysm Repair for Treatment of Type Ia Endoleak After EVAR.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2026

Injection-based safety of aqueous venom immunotherapy during venom extract shortage: impact of forced depot-to-aqueous switching.

Immunotherapy·2026

Intrathecal Ropivacaine Versus Levobupivacaine for Infraumbilical Surgery: A Randomized Double-Blind Trial.

Cureus·2026

Bypassing the bypass: complex laparoscopic reparation of internal hernia after laparotomic Roux-en-Y gastric bypass.

Journal of surgical case reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us